We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Hershey
HSY
$35.4B
| $65.5M | 0.68% |
457,031
+16,749
| +4% | +$2.38M |
|
27
Fortinet
FTNT
$112B
| $64.7M | 0.67% |
2,747,510
+31,755
| +1% | +$820K |
|
28
Synchrony
SYF
$23.7B
| $62.7M | 0.65% |
2,397,178
+17,915
| +0.8% | +$435K |
|
29
Corteva
CTVA
$59.7B
| $62.7M | 0.65% |
2,177,028
+540,681
| +33% | +$15.2M |
|
30
Travelers Companies
TRV
$80.8B
| $61.2M | 0.63% |
565,669
+41,497
| +8% | +$4.76M |
|
31
Synaptics
SYNA
$4.41B
| $58.1M | 0.6% |
722,536
-53,613
| -7% | -$4.24M |
|
32
RenaissanceRe
RNR
$13.7B
| $56.1M | 0.58% |
330,683
+9,588
| +3% | +$1.7M |
|
33
Gaming and Leisure Properties
GLPI
$12.8B
| $55.4M | 0.57% |
1,499,276
+91,708
| +7% | +$3.34M |
|
34
Micron Technology
MU
$1.04T
| $55.2M | 0.57% |
1,175,860
+89,449
| +8% | +$4.33M |
|
35
Hewlett Packard
HPE
$63.2B
| $54.8M | 0.57% |
5,847,465
+1,263,946
| +28% | +$12.1M |
|
36
AGCO
AGCO
$8.78B
| $54.8M | 0.57% |
737,299
+27,569
| +4% | +$1.88M |
|
37
NetApp
NTAP
$32.9B
| $53.8M | 0.56% |
1,228,124
+87,461
| +8% | +$3.82M |
|
38
United Therapeutics
UTHR
$26.3B
| $53.4M | 0.55% |
528,566
+77,308
| +17% | +$8.48M |
|
39
Eli Lilly
LLY
$1.07T
| $53.2M | 0.55% |
359,275
-204,763
| -36% | -$31.7M |
|
40
Western Digital
WDC
$179B
| $52.9M | 0.55% |
1,913,136
+462,949
| +32% | +$13.8M |
|
41
Incyte
INCY
$23.5B
| $51.8M | 0.54% |
577,269
+193,571
| +50% | +$18.7M |
|
42
Expeditors International
EXPD
$22.9B
| $51.7M | 0.54% |
571,169
+14,357
| +3% | +$1.22M |
|
|
43
Capital One
COF
$124B
| $50.3M | 0.52% |
699,303
+549,248
| +366% | +$36.7M |
|
44
Arrow Electronics
ARW
$10.9B
| $49.8M | 0.52% |
632,512
+17,025
| +3% | +$1.26M |
|
45
Green Dot
GDOT
$753M
| $49M | 0.51% |
969,118
-75,214
| -7% | -$3.86M |
|
46
Reinsurance Group of America
RGA
$15.7B
| $44.6M | 0.46% |
468,594
+22,428
| +5% | +$2.02M |
|
47
Viatris
VTRS
$20.1B
| $43.9M | 0.46% |
2,963,504
+272,710
| +10% | +$4.35M |
|
48
Landstar System
LSTR
$6.8B
| $43.7M | 0.45% |
348,413
+19,080
| +6% | +$2.4M |
|
49
Take-Two Interactive
TTWO
$43B
| $42.6M | 0.44% |
257,760
+5,317
| +2% | +$864K |
|
|
JNPR
50
DELISTED
Juniper Networks
JNPR
| $41.3M | 0.43% |
1,920,294
+143,397
| +8% | +$3.4M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.